These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1615221)

  • 21. The treatment of prostatic cancer by LH-RH agonist.
    Imai K; Yamanaka H; Yuasa H; Yoshida M; Asano M; Kaetsu I
    Prog Clin Biol Res; 1987; 243A():429-34. PubMed ID: 3116552
    [No Abstract]   [Full Text] [Related]  

  • 22. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.
    Schally AV
    Peptides; 1999; 20(10):1247-62. PubMed ID: 10573298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New gonadotropin-releasing hormone glycolipids with direct antiproliferative activity and gonadotropin-releasing potency.
    Varamini P; Mansfeld FM; Giddam AK; Steyn F; Toth I
    Int J Pharm; 2017 Apr; 521(1-2):327-336. PubMed ID: 28232269
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
    Nagy A; Schally AV
    Biol Reprod; 2005 Nov; 73(5):851-9. PubMed ID: 16033997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer.
    Nicholson RI; Walker KJ; Turkes A; Turkes AO; Dyas J; Blamey RW; Campbell FC; Robinson MR; Griffiths K
    J Steroid Biochem; 1984 Jan; 20(1):129-35. PubMed ID: 6231416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers.
    Redding TW; Schally AV
    Prog Clin Biol Res; 1988; 262():217-40. PubMed ID: 2897695
    [No Abstract]   [Full Text] [Related]  

  • 27. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
    Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
    Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Homologues of gonadotropin releasing factors].
    Agostino A; Simeoni A; Altomonte G; Jacobelli A
    Clin Ter; 1987 Mar; 120(5):427-32. PubMed ID: 2953542
    [No Abstract]   [Full Text] [Related]  

  • 29. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
    Kadar T; Redding TW; Ben-David M; Schally AV
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):890-4. PubMed ID: 2893378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [LH-RH derivative].
    Miyake H; Fujisawa M
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():313-6. PubMed ID: 25831774
    [No Abstract]   [Full Text] [Related]  

  • 31. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gonadoliberin. Therapeutic prospects].
    Sitruk-Ware R; Le Bouc Y; Gompel A; Mauvais-Jarvis P
    Presse Med; 1984 Mar; 13(9):553-8. PubMed ID: 6230650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic carcinoma of the prostate in both testes of patients treated with LH-RH analogues.
    Hadjissotiriou GG; Papadopoulos S; Rebelakos A
    Br J Urol; 1992 Jun; 69(6):657-9. PubMed ID: 1386273
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.
    Yano T; Pinski J; Radulovic S; Schally AV
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1701-5. PubMed ID: 8127868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of LHRH and its analogs].
    Smals AG
    Ned Tijdschr Geneeskd; 1985 Jan; 129(1):15-20. PubMed ID: 2857478
    [No Abstract]   [Full Text] [Related]  

  • 37. [The LH-RH analogs. Drug treatment of prostate cancer].
    Gerson C
    Soins; 1995 Nov; (600):61-2. PubMed ID: 8715119
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of receptors for luteinizing hormone-releasing hormone (LH-RH) in prostate cancers following therapy with LH-RH agonists.
    Liu SV; Schally AV; Hawes D; Xiong S; Fazli L; Gleave M; Cai J; Groshen S; Brands F; Engel J; Pinski J
    Clin Cancer Res; 2010 Sep; 16(18):4675-80. PubMed ID: 20670943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gonadotropin-releasing hormone analogues in the treatment of metastatic breast carcinoma].
    Nesković-Konstantinović Z; Radulović S; Vuletić L
    Srp Arh Celok Lek; 1993; 121(1-2):33-5. PubMed ID: 8202820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
    Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
    Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.